TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitors
about
TACC3 as an independent prognostic marker for solid tumors: a systematic review and meta-analysis.Clinicopathological and prognostic value of transforming acidic coiled-coil-containing protein 3 (TACC3) expression in soft tissue sarcomas.Vorinostat-eluting poly(DL-lactide-co-glycolide) nanofiber-coated stent for inhibition of cholangiocarcinoma cells.TACC3 transcriptionally upregulates E2F1 to promote cell growth and confer sensitivity to cisplatin in bladder cancer.Enhancement of the efficiency of oocyte vitrification through regulation of histone deacetylase 6 expression
P2860
TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitors
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
TACC3 overexpression in cholan ...... rug target for HDAC inhibitors
@en
TACC3 overexpression in cholan ...... ug target for HDAC inhibitors.
@nl
type
label
TACC3 overexpression in cholan ...... rug target for HDAC inhibitors
@en
TACC3 overexpression in cholan ...... ug target for HDAC inhibitors.
@nl
prefLabel
TACC3 overexpression in cholan ...... rug target for HDAC inhibitors
@en
TACC3 overexpression in cholan ...... ug target for HDAC inhibitors.
@nl
P2093
P2860
P356
P1433
P1476
TACC3 overexpression in cholan ...... rug target for HDAC inhibitors
@en
P2093
Jian Zhang
Jian-Ming Wang
Jun-Chuang He
Peter Schemmer
Wei-Peng Qi
Ya-Wei Qian
P2860
P304
75441-75456
P356
10.18632/ONCOTARGET.12254
P407
P577
2016-09-26T00:00:00Z